A Review of the Use of Infliximab to Manage Cutaneous Dermatoses
@article{Gupta2004ARO, title={A Review of the Use of Infliximab to Manage Cutaneous Dermatoses}, author={A. Gupta and A. R. Skinner}, journal={Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology}, year={2004}, volume={8}, pages={77-89} }
BackgroundInfliximab is a chimeric monoclonal antibody that binds specifically to human tumor necrosis factor-alpha (TNF-α), decreasing the effect of the cytokine in inflammatory diseases.ObjectiveThe aim of this study was to review the efficacy and safety of infliximab in the treatment of dermatological diseases.MethodsA MEDLINE search (1966–January 2003), using the keyword “infliximab” was performed to find relevant articles pertaining to the use of infliximab in dermatology.ResultsInfliximab… CONTINUE READING
Topics from this paper
56 Citations
Lymphoedematous variants of Kaposi's sarcoma
- Medicine
- Journal of the European Academy of Dermatology and Venereology : JEADV
- 2008
- 21
Infliximab in dermatological treatment: beyond psoriasis
- Medicine
- Expert opinion on biological therapy
- 2008
- 19
Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
- Medicine
- Acta dermato-venereologica
- 2008
- 51
- PDF
The use of infliximab in dermatology
- Medicine
- Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
- 2007
- 15
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases
- Medicine
- International journal of dermatology
- 2007
- 53
- PDF
[Hidradenitis suppurativa. Response to treatment with infliximab].
- Medicine
- Actas dermo-sifiliograficas
- 2007
- 20
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab
- Medicine
- Journal of the European Academy of Dermatology and Venereology : JEADV
- 2008
- 29
[Efficacy of etanercept in the treatment of acne conglobata].
- Medicine
- Actas dermo-sifiliograficas
- 2010
- 3
References
SHOWING 1-10 OF 113 REFERENCES
The effectiveness of tumor necrosis factor alpha antibody (infliximab) in treating recalcitrant psoriasis: a report of 2 cases.
- Medicine
- Archives of dermatology
- 2002
- 65
- PDF
Treatment of Complicated Sarcoidosis with Infliximab AntiTumor Necrosis Factor- Therapy
- Medicine
- Annals of Internal Medicine
- 2001
- 182
Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).
- Medicine
- Archives of dermatology
- 2001
- 85
- PDF
Behçet’s disease: a new target for anti-tumour necrosis factor treatment
- Medicine
- Annals of the rheumatic diseases
- 2002
- 200
- PDF
Drug‐induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N‐acetylcysteine
- Medicine
- The British journal of dermatology
- 1997
- 71
Successful treatment of SAPHO syndrome with infliximab: report of two cases
- Medicine
- Annals of the rheumatic diseases
- 2002
- 76
- PDF
Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab.
- Medicine
- Journal of the American Academy of Dermatology
- 2002
- 106
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis.
- Medicine
- Rheumatology
- 2002
- 239
- PDF